Hologic (HOLX) Tops Q2 EPS by 1c; Lifts Outlook

Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $818.4 million versus the consensus estimate of $806.5 million.

GUIDANCE:

Hologic sees Q3 2019 EPS of $0.60-$0.62, versus the consensus of $0.62. Hologic sees Q3 2019 revenue of $825-840 million, versus the consensus of $840.02 million.

Hologic sees FY2019 EPS of $2.41-$2.44, versus the consensus of $2.41. Hologic sees FY2019 revenue of $3.325-3.345 billion, versus the consensus of $3.32 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Hologic recalls BioZorb markers after reported injuries - FDA
• Xiaomi, Oppo, Vivo slash shipment targets up to 30% amid memory crunch - Nikkei
• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs